| scholarly article | Q13442814 |
| P356 | DOI | 10.1172/JCI106458 |
| P953 | full work available at URL | https://europepmc.org/articles/PMC322740 |
| https://europepmc.org/articles/PMC322740?pdf=render | ||
| P932 | PMC publication ID | 322740 |
| P698 | PubMed publication ID | 5480862 |
| P2093 | author name string | E. W. Sutherland | |
| J. G. Hardman | |||
| D. J. Jones | |||
| G. W. Liddle | |||
| A. E. Broadus | |||
| Jones DJ Jr | |||
| J. H. Ball | |||
| N. I. Kaminsky | |||
| P2860 | cites work | The effect of epinephrine on adenosine 3', 5'-phosphate levels in the isolated perfused rat heart | Q72569966 |
| Adenosine 3',5'-monophosphate as the intracellular mediator of the action of adrenocorticotropic hormone on the adrenal cortex | Q77225204 | ||
| Adenosine 3',5'-phosphate in biological materials. I. Purification and properties of cyclic 3',5'-nucleotide phosphodiesterase and use of this enzyme to characterize adenosine 3',5'-phosphate in human urine | Q79360576 | ||
| Pseudohypoparathyroidism: defective excretion of 3',5'-AMP in response to parathyroid hormone | Q35573411 | ||
| Kinetic parameters and renal clearances of plasma adenosine 3',5'-monophosphate and guanosine 3',5'-monophosphate in man. | Q35581901 | ||
| Effects of glucagon on adenosine 3',5'-monophosphate and guanosine 3',5'-monophosphate in human plasma and urine | Q35581931 | ||
| Parathyroid function and the renal excretion of 3'5'-adenylic acid | Q35974238 | ||
| Cyclic adenosine monophosphate, CA++, and membranes | Q36471418 | ||
| Cyclic AMP. | Q39890323 | ||
| The role of cyclic AMP in hormone actions | Q39891156 | ||
| Polypeptide hormones and calcium metabolism | Q39982370 | ||
| Effect of dibutyryl cyclic adenosine 3',5'-monophosphate, theophylline, and other nucleotides upon calcium and phosphate metabolism | Q40350409 | ||
| The effects of the catecholamines, adrenergic blocking agents, prostaglandin E1, and insulin on cyclie AMP levels in the rat epididymal fat pad in vitro | Q44490368 | ||
| Effects of some hormonal and other factors on the excretion of guanosine 3',5'-monophosphate and adenosine 3',5'-monophosphate in rat urine | Q48959691 | ||
| The influence of chemical agents on the accumulation of adenosine 3',5'-Phosphate in slices of rabbit cerebellum. | Q51183829 | ||
| Determination of serum and urine calcium. | Q53025043 | ||
| Activation of skeletal adenyl cyclase by parathyroid hormone in vitro. | Q53807240 | ||
| Study of parathyroid function in man by EDTA infusion. | Q54053386 | ||
| Parathyroid Hormone-like Action of N6-2′-O-Dibutyryladenosine-3′5′ (Cyclic)-Monophosphate on Bone Explants in Tissue Culture | Q59086441 | ||
| Hypercalcemic and hypophosphatemic effects of dibutyryl cyclic AMP in rats after parathyroidectomy | Q68589693 | ||
| Renal adenyl cyclase: anatomically separate sites for parathyroid hormone and vasopressin | Q72015836 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2387-2395 | |
| P577 | publication date | 1970-12-01 | |
| P1433 | published in | Journal of Clinical Investigation | Q3186904 |
| P1476 | title | Effects of parathyroid hormone on plasma and urinary adenosine 3′,5′-monophosphate in man | |
| P478 | volume | 49 |
| Q37352747 | A short history of cGMP, guanylyl cyclases, and cGMP-dependent protein kinases |
| Q30449746 | A simple, sensitive protein-binding assay for guanosine 3':5'-monophosphate |
| Q69807138 | A simplified diagnostic test in hypoparathyroidism and pseudohypoparathyroidism type I with synthetic 1-38 fragment of human parathyroid hormone |
| Q72907765 | Acute effects of increased meat protein on urinary electrolytes and cyclic adenosine monophosphate and serum parathyroid hormone |
| Q28567019 | Acute parathyroid hormone differentially regulates renal brush border membrane phosphate cotransporters |
| Q40293866 | Acute response of parathyroid hormone in congenital osteopetrosis |
| Q54563312 | Altered Vitamin D, Cyclic Nucleotide and Trace Mineral Metabolism in the X-Linked Hypophosphatemic Mouse |
| Q70197033 | Altered levels of cyclic nucleotides in F344 rats fed sodium o-phenylphenate |
| Q40215544 | Anomalies of cyclic AMP excretion in some abnormal offenders |
| Q39919521 | Antagonism between parathyroid hormone and norepinephrine on cyclic adenosine-3?:5?-monophosphate (cAMP) levels in isolated tubules from rat kidney cortex |
| Q46345702 | Asymmetric release of cyclic AMP from guinea-pig and rabbit gallbladder |
| Q40029944 | Basal and hormone-induced urinary cyclic AMP in children with renal disorders |
| Q36424831 | Bone lesions and dental caries after gastrectomy--evaluation of milk intolerance and operative procedure |
| Q40273528 | Changes of urinary cyclic AMP excretion and plasma parathyroid hormone levels before and after parathyroidectomy in patients with primary hyperparathyroidism |
| Q41368622 | Cyclic AMP in gastric juice does not reflect histamine H2 receptor activity in Heidenhain pouch dog. |
| Q34252220 | Cyclic AMP metabolism and adenylate cyclase concentration in patients with advanced hepatic cirrhosis |
| Q40041860 | Cyclic Adenosine Monophosphate: Relationship to Calcium Metabolism and Renal Lithiasis |
| Q38225686 | Cyclic Nucleotide Metabolism in Solid Tumor Tissues |
| Q40082058 | Cyclic adenosine monophosphate and human gastric acid secretion |
| Q43946910 | Cyclic adenosine monophosphate and renal failure (author's transl) |
| Q40247927 | Cyclic nucleotides in renal tissue and urine during graded expansion of extracellular fluid volume in intact and acutely parathyroidectomized rats |
| Q72882227 | Differential diagnosis of hypoparathyroid disorders during childhood |
| Q39983754 | Early effects of synthetic bovine parathyroid hormone and synthetic salmon calcitonin on urinary excretion of cyclic AMP, phosphate and calcium in man |
| Q41668573 | Effect of acute metabolic acidemia on renal electrolyte transport in man |
| Q39953778 | Effect of hypoglycemia on extracellular levels of cyclic AMP in man |
| Q40060106 | Effect of parathyroid hormone and cyclic adenosine 3′, 5′-monophosphate on isotonic fluid reabsorption: Polarity of proximal tubular cells |
| Q35938176 | Effect of propranolol on cyclic AMP excretion and plasma renin activity in labile essentrial hypertension |
| Q39941790 | Effect of surgical trauma on plasma concentrations of cyclic AMP and cortisol |
| Q34073340 | Effects of catecholamines and adrenergic-blocking agents on plasma and urinary cyclic nucleotides in man. |
| Q34495888 | Effects of dibutyryl cyclic adenosine 3',5'-monophosphate and parathyroid extract on calcium and phosphorus metabolism in hypoparathyroidism and pseudohypoparathyroidism |
| Q35581931 | Effects of glucagon on adenosine 3',5'-monophosphate and guanosine 3',5'-monophosphate in human plasma and urine |
| Q40167056 | Evaluation of renal cyclic adenosine monophosphate, serum parathyroid hormone and phosphate reabsorption in recurrent calcium urolithiasis, healthy controls and hyperparathyroidism (author's transl) |
| Q35902586 | Exaggerated phosphaturic response to circulating parathyroid hormone in patients with familial X-linked hypophosphatemic rickets |
| Q39988240 | Experimental induction of hypoparathyroidism with parathyroid hormone antibodies |
| Q27312238 | Expression of Tight Junction Proteins and Cadherin 17 in the Small Intestine of Young Goats Offered a Reduced N and/or Ca Diet |
| Q34520624 | Extracellular cAMP inhibits proximal reabsorption: are plasma membrane cAMP receptors involved? |
| Q39894380 | Extracellular cyclic nucleotides |
| Q40037711 | Extracellular metabolism of cyclic AMP |
| Q71979406 | Extracellular nucleotides as modulators of renal tubular transport |
| Q40132597 | Fasting plasma cyclic AMP levels in an adult diabetic and non-diabetic group |
| Q67251960 | Functional Properties of Parathyroid Hormone Receptors in Kidney and Bone |
| Q39946295 | Hepatic clearance of adenosine 3′:5′-cyclic monophosphate from plasma in the rat |
| Q41790045 | Hormonal control of gluconeogenesis in tubule fragments from renal cortex of fed rats. Effects of α-adrenergic stimuli, glucagon, theophylline and papaverine |
| Q40102921 | Hypercalcemia and urinary excretion of cyclic AMP in bronchogenic carcinoma |
| Q40143777 | Hypercalcemia with suppressed parathyroid hormone in Burkitt's lymphoma |
| Q66923422 | Hypercalciuria in idiopathic fanconi syndrome |
| Q40060116 | Hyperparathyroidism: Influence of glomerular filtration rate on urinary excretion of cyclic AMP |
| Q35046562 | Immunohistochemical localization of 3′:5′-cyclic AMP and 3′:5′-cyclic GMP in rat renal cortex: Effect of parathyroid hormone |
| Q72910628 | Influence of Calcium Infusion on Urinary Cyclic AMP and Phosphate in Hyperparathyroidism |
| Q35581901 | Kinetic parameters and renal clearances of plasma adenosine 3',5'-monophosphate and guanosine 3',5'-monophosphate in man. |
| Q39981806 | Magnesium Depletion and Hypocalcaemia after Removal of A Parathyroid Carcinoma |
| Q72867735 | Metabolic aspects of bone resorption in calcium-deficient lactating rats |
| Q39951888 | Metabolism of Isolated Kidney Tubules Independent Actions of Catecholamines on Renal Cyclic Adenosine 3': 5'-Monophosphate Levels and Gluconeogenesis |
| Q88613804 | Modulation of renal calcium and phosphate transporting proteins by dietary nitrogen and/or calcium in young goats |
| Q40250452 | Myocardial extraction of cyclic AMP during pacing-induced angina |
| Q37047201 | Nephrogenous Cyclic Adenosine Monophosphate as a Parathyroid Function Test |
| Q40062486 | Nonautonomy of parathyroid hormone and urinary cyclic AMP in primary hyperparathyroidism |
| Q39975186 | On the lipolytic action of parathyroid hormone in man |
| Q39937927 | Origin of Cyclic Adenosine Monophosphate in Saliva |
| Q40133727 | Parathyroid Hormone: Chemistry, Biosynthesis, and Mode of Action |
| Q39902848 | Parathyroid hormone and calcitonin regulation of renal function |
| Q34497782 | Pathogenesis of hypocalcemia in primary hypomagnesemia: normal end-organ responsiveness to parathyroid hormone, impaired parathyroid gland function |
| Q40368741 | Pathogenic role of cyclic AMP in the impairment of urinary concentrating ability in acute hypercalcemia |
| Q35885772 | Phosphate and the development of nephrocalcinosis in rats fed diets containing alpha protein. |
| Q67916547 | Plasma Cyclic AMP Response to Intravenous Parathyroid Hormone in Pseudohypoparathyroidism |
| Q34459651 | Plasma clearance rates and renal clearance of 3H-labeled cyclic AMP and 3H-labeled cyclic GMP in the dog. |
| Q40163433 | Plasma cyclic AMP in manic-depressive illness |
| Q40251684 | Plasma cyclic-AMP response to parathyroid hormone in Turner's syndrome and Albright's hereditary osteodystrophy |
| Q40021920 | Plasma-cAMP in primary and secondary hyperparathyroidism (author's transl) |
| Q37767040 | Prostaglandin-mediated hypercalcemia: A paraneoplastic syndrome |
| Q27023655 | Regulation of nephron water and electrolyte transport by adenylyl cyclases |
| Q37047394 | Relationship between Phosphaturia and Acute Hypercapnia in the Rat |
| Q70195009 | Release of cAMP from a renal epithelial cell line |
| Q70201055 | Renal 1,25-dihydroxyvitamin D, phosphaturic, and cyclic-AMP responses to intravenous synthetic human parathyroid hormone-(1-34) administration in normal subjects |
| Q28320820 | Renal cyclic adenosine monophosphate: An accurate index of parathyroid function |
| Q68641075 | Renal handling of 3'-5'-cyclic AMP in the rat. The possible role of luminal 3'-5'-cyclic AMP in the tubular reabsorption of phosphate |
| Q72872391 | Renal parathyroid hormone-dependent adenylate cyclase in vitamin D-deficient rats. Inhibition by hydroxylated vitamin D3 metabolites |
| Q40167448 | Response of 1α,25-Dihydroxyvitamin D3to Hypocalcemia in Human Subjects |
| Q34992424 | Role of MRP4 and MRP5 in biology and chemotherapy |
| Q41022405 | Role of renal handling of extracellular nucleotides in modulation of phosphate transport |
| Q34366508 | Role of the extracellular cAMP-adenosine pathway in renal physiology |
| Q70152673 | Salmon calcitonin and cGMP production by human kidney: studies in vivo and in vitro |
| Q67248491 | Sclerosing hepatic carcinoma: relationship to hypercalcemia |
| Q50584424 | Seasonal variation in urinary excretion of cyclic AMP in healthy people |
| Q34459722 | Sources of cyclic nucleotides in plasma |
| Q35195106 | Studies of the elevated extracellular concentration of cyclic AMP in uremic man |
| Q35900259 | Study of the renal tubular interactions of thyrocalcitonin, cyclic adenosine 3',5'-monophosphate, 25-hydroxycholecalciferol, and calcium ion |
| Q39942265 | Symposium on acid-base homeostasis. Renal acidosis |
| Q72918190 | The 24-h urinary cyclic adenosine 3′, 5′-monophosphate/creatinine ratio: an useful approach to the diagnosis of parathyroid disorders and function |
| Q72867012 | The Phosphaturic Action of PTH in the Steady State in Patients with Normal and Impaired Renal Function |
| Q39942666 | The Sources of Plasma Cyclic AMP: Studies in the Rat using Isoprenaline, Nicotinic Acid and Glucagon |
| Q70151573 | The cyclic-AMP concentration in plasma and in muscle in response to exercise and beta-blockade in man |
| Q51743253 | The effect of ECT on plasma cyclic nucleotides: a simulated ECT controlled study in melancholic patients. |
| Q72117762 | The effect of endogenous parathyroid hormone, exogenous calcitonin, and dibutyryl cyclic AMP on urinary excretion of N-acetyl-beta-D-glucosaminidase |
| Q34465118 | The hypercalciurias. Causes, parathyroid functions, and diagnostic criteria |
| Q34052040 | The pathophysiology and clinical aspects of hypercalcemic disorders |
| Q70151068 | The role of renal prostaglandin E as a possible modulator of cyclic AMP production in nephrotic syndrome |
| Q40236219 | The urine cyclic AMP response to parathyroid extract (PTE) administration in normal subjects and patients with parathyroid dysfunction |
| Q34987702 | Urinary 3'5' cyclic AMP. Diagnostic test in pseudohypoparathyroidism |
| Q40014075 | Urinary Adenosine 3’,5′-Cyclic Monophosphate: Effects of Electroconvulsive Therapy |
| Q72948232 | Urinary Cyclic AMP Corrected for Glomerular Filtration Rate in the Differential Diagnosis of Hypercalcemia |
| Q39984407 | Urinary Excretion of Adenosine 3'5‘ Monophosphate in Vitamin D Deficiency |
| Q35905423 | Urinary cyclic AMP analyzed as a function of the serum calcium and parathyroid hormone in the idfferential diagnosis of hypercalcemia |
| Q54715028 | Urinary cyclic adenosine monophosphate as an aid in the diagnosis of hyperparathyroidism. |
| Q36595310 | Urinary cyclic adenosine monophosphate in young adults and elderly subjects |
| Q40239103 | Urinary excretion of cyclic AMP in bacterial infections |
| Q33846489 | Urinary excretion of cyclic adenosine 3',5'-monophosphate and cyclic guanosine 3',5'-monophosphate in malignancy |
| Q40184721 | Urinary phosphate and cyclic AMP excretion following citrate-induced hypocalcemic stimulation of the neonatal parathyroid glands |
| Q40018317 | Variations in the content of cyclic adenosine monophosphate in human mixed saliva during physiological stimulation |
| Q54063165 | [Regulation of tumor growth by adenosine-3',5'-monophosphate]. |
Search more.